Is HuVePharma still active?

Yes, HuVePharma is currently active.

Where is HuVePharma registered?

HuVePharma's registered address is Uitbreidingstraat 80, 2600 Antwerpen, Belgium.

How many employees does HuVePharma have?

Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2025), HuVePharma reported 102.2 full-time equivalent employees.

What is HuVePharma's annual turnover?

HuVePharma's most recently filed annual turnover (fiscal year ending 31 Dec 2025) was €127,095,181.

Did HuVePharma make a profit or a loss?

HuVePharma's most recently filed annual accounts (fiscal year ending 31 Dec 2025) reported a profit of €5,890,253.

When did HuVePharma last file annual accounts?

HuVePharma's most recently filed annual accounts cover the fiscal year ending 31 Dec 2025.

Is HuVePharma B Corp certified?

We have no B Corp certification on file for HuVePharma.

Does HuVePharma hold Fairtrade certification?

No, HuVePharma does not currently hold Fairtrade certification.

HuVePharma

Q: When was HuVePharma founded?

HuVePharma was founded on 27 Jul 2005, making it 21 years old.

Q: What does HuVePharma do?

HuVePharma's registered main activities are Wholesale of other food n.e.c., Wholesale of cattle feeds and agricultural products, general selection, and Wholesale of grain and seeds. It is also registered for 2 additional activities.

BE 0875.283.062

Copied!

NV/SA

Status

Active

Founded

27 Jul 2005

Size

Large · 102.2 FTE

Age

21 yrs

Main activity

Wholesale of other food n.e.c.

Activities

5 activities

Wholesale of other food n.e.c.Wholesale of cattle feeds and agricultural products, general selectionWholesale of grain and seedsWholesale of animal feedsOther business support service activities n.e.c.

Financials

Turnover2025

€127M+10.5%

Profit / Loss2025

€5.9M+23.3%

Equity2025

€49.8M+13.4%

2025	2024	2023	2022
€127,095,181+10.5%	€115,026,597+14.7%	€100,297,083-0.4%	€100,702,342
€5,890,253+23.3%	€4,777,338+11.4%	€4,288,792-1.2%	€4,340,052
€49,777,357+13.4%	€43,887,104+12.2%	€39,109,766+12.3%	€34,820,974
€57,911,661+7.9%	€53,653,181+23.2%	€43,544,538-5.9%	€46,301,346
€4,591,821-20.8%	€5,797,695+33.1%	€4,355,909-6.4%	€4,654,847
102.2+24.6%	82+1.2%	81+2.1%	79.3
€1,243,593-11.3%	€1,402,763+13.3%	€1,238,236-2.5%	€1,269,891

Frequently asked questions

01What is HuVePharma's official registered name?

HuVePharma.

02What is HuVePharma's enterprise number (VAT number)?

BE 0875.283.062.

03What is HuVePharma's legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

04When was HuVePharma founded?

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

	2025	2024	2023	2022
Income statement
	€127,095,181+10.5%	€115,026,597+14.7%	€100,297,083-0.4%	€100,702,342
	€16,902,324+41%	€11,988,476+0.8%	€11,889,365+13%	€10,521,630
	€8,434,100+23.2%	€6,844,591+8.7%	€6,298,175-2.2%	€6,441,122
	€21,517,526	—	—	€17,793,978
	€5,890,253+23.3%	€4,777,338+11.4%	€4,288,792-1.2%	€4,340,052
	€2,043,813+80.3%	€1,133,544+1.8%	€1,113,995-10.7%	€1,247,906
Profitability
	16.9%	—	—	17.7%
	4.6%+11.6%	4.2%-2.9%	4.3%-0.8%	4.3%
	11.8%+8.7%	10.9%-0.7%	11.0%-12%	12.5%
	5.5%+11.7%	4.9%-5.6%	5.2%-3%	5.4%
Solvency
	€107,689,018+10.4%	€97,540,285+18%	€82,654,304+1.9%	€81,122,320
	€934,599+12.7%	€829,193+3.2%	€803,531+16.7%	€688,375
	€235,109-18.6%	€288,932+11.3%	€259,709-1.5%	€263,693
	€49,777,357+13.4%	€43,887,104+12.2%	€39,109,766+12.3%	€34,820,974
	46.2%+2.7%	45.0%-4.9%	47.3%+10.2%	42.9%
	€27,857-67.9%	€86,781-31.1%	€126,022+287.6%	€32,510
	0.00-71.7%	0.00-38.6%	0.00+245.1%	0.00
	€57,911,661+7.9%	€53,653,181+23.2%	€43,544,538-5.9%	€46,301,346
	1.16-4.8%	1.22+9.8%	1.11-16.3%	1.33
	49.14-24.9%	65.43-9%	71.88-39%	117.78
Liquidity
	€4,591,821-20.8%	€5,797,695+33.1%	€4,355,909-6.4%	€4,654,847
	€28,548,483+7.8%	€26,477,796+19.3%	€22,199,948-10.1%	€24,702,125
	€15,941,226+19.5%	€13,338,545+11.5%	€11,968,712+25.3%	€9,548,758
	€47,211,169+3.2%	€45,756,302+27.8%	€35,813,483-8.3%	€39,061,645
	€50,500,183+4.9%	€48,139,351+26.7%	€38,000,708-7.9%	€41,279,137
	0.81+1.5%	0.80-4.9%	0.84+7.3%	0.79
	-€6,135,870-28.8%	-€4,765,136-98.4%	-€2,402,144+53.7%	-€5,188,911
Efficiency
	46 days+8.2%	42 days-2.8%	44 days+25.9%	35 days
	128 days-7.5%	138 days+9.3%	126 days-9%	139 days
	103 days-3%	107 days+1.1%	105 days-7.9%	114 days
	3.66-1.9%	3.73+13.7%	3.28+0.3%	3.27
Profit appropriation
	€13,853,899+7.7%	€12,864,549+8.3%	€11,875,199+9.1%	€10,885,849
	€31,423,458+18.5%	€26,522,555+16.7%	€22,734,567+17%	€19,435,125

Sources

NBB — Nationale Bank van België

	2025	2024	2023	2022
Income statement
	€127,095,181+10.5%	€115,026,597+14.7%	€100,297,083-0.4%	€100,702,342
	€16,902,324+41%	€11,988,476+0.8%	€11,889,365+13%	€10,521,630
	€8,434,100+23.2%	€6,844,591+8.7%	€6,298,175-2.2%	€6,441,122
	€21,517,526	—	—	€17,793,978
	€5,890,253+23.3%	€4,777,338+11.4%	€4,288,792-1.2%	€4,340,052
	€2,043,813+80.3%	€1,133,544+1.8%	€1,113,995-10.7%	€1,247,906
Profitability
	16.9%	—	—	17.7%
	4.6%+11.6%	4.2%-2.9%	4.3%-0.8%	4.3%
	11.8%+8.7%	10.9%-0.7%	11.0%-12%	12.5%
	5.5%+11.7%	4.9%-5.6%	5.2%-3%	5.4%
Solvency
	€107,689,018+10.4%	€97,540,285+18%	€82,654,304+1.9%	€81,122,320
	€934,599+12.7%	€829,193+3.2%	€803,531+16.7%	€688,375
	€235,109-18.6%	€288,932+11.3%	€259,709-1.5%	€263,693
	€49,777,357+13.4%	€43,887,104+12.2%	€39,109,766+12.3%	€34,820,974
	46.2%+2.7%	45.0%-4.9%	47.3%+10.2%	42.9%
	€27,857-67.9%	€86,781-31.1%	€126,022+287.6%	€32,510
	0.00-71.7%	0.00-38.6%	0.00+245.1%	0.00
	€57,911,661+7.9%	€53,653,181+23.2%	€43,544,538-5.9%	€46,301,346
	1.16-4.8%	1.22+9.8%	1.11-16.3%	1.33
	49.14-24.9%	65.43-9%	71.88-39%	117.78
Liquidity
	€4,591,821-20.8%	€5,797,695+33.1%	€4,355,909-6.4%	€4,654,847
	€28,548,483+7.8%	€26,477,796+19.3%	€22,199,948-10.1%	€24,702,125
	€15,941,226+19.5%	€13,338,545+11.5%	€11,968,712+25.3%	€9,548,758
	€47,211,169+3.2%	€45,756,302+27.8%	€35,813,483-8.3%	€39,061,645
	€50,500,183+4.9%	€48,139,351+26.7%	€38,000,708-7.9%	€41,279,137
	0.81+1.5%	0.80-4.9%	0.84+7.3%	0.79
	-€6,135,870-28.8%	-€4,765,136-98.4%	-€2,402,144+53.7%	-€5,188,911
Efficiency
	46 days+8.2%	42 days-2.8%	44 days+25.9%	35 days
	128 days-7.5%	138 days+9.3%	126 days-9%	139 days
	103 days-3%	107 days+1.1%	105 days-7.9%	114 days
	3.66-1.9%	3.73+13.7%	3.28+0.3%	3.27
Profit appropriation
	€13,853,899+7.7%	€12,864,549+8.3%	€11,875,199+9.1%	€10,885,849
	€31,423,458+18.5%	€26,522,555+16.7%	€22,734,567+17%	€19,435,125

2025

2024

2023

2022

Income statement

€127,095,181+10.5%

€115,026,597+14.7%

€100,297,083-0.4%

€100,702,342

€16,902,324+41%

€11,988,476+0.8%

€11,889,365+13%

€10,521,630

€8,434,100+23.2%

€6,844,591+8.7%

€6,298,175-2.2%

€6,441,122

€21,517,526

—

€17,793,978

€5,890,253+23.3%

€4,777,338+11.4%

€4,288,792-1.2%

€4,340,052

€2,043,813+80.3%

€1,133,544+1.8%

€1,113,995-10.7%

€1,247,906

Profitability

16.9%

—

17.7%

4.6%+11.6%

4.2%-2.9%

4.3%-0.8%

4.3%

11.8%+8.7%

10.9%-0.7%

11.0%-12%

12.5%

5.5%+11.7%

4.9%-5.6%

5.2%-3%

5.4%

Solvency

€107,689,018+10.4%

€97,540,285+18%

€82,654,304+1.9%

€81,122,320

€934,599+12.7%

€829,193+3.2%

€803,531+16.7%

€688,375

€235,109-18.6%

€288,932+11.3%

€259,709-1.5%

€263,693

€49,777,357+13.4%

€43,887,104+12.2%

€39,109,766+12.3%

€34,820,974

46.2%+2.7%

45.0%-4.9%

47.3%+10.2%

42.9%

€27,857-67.9%

€86,781-31.1%

€126,022+287.6%

€32,510

0.00-71.7%

0.00-38.6%

0.00+245.1%

0.00

€57,911,661+7.9%

€53,653,181+23.2%

€43,544,538-5.9%

€46,301,346

1.16-4.8%

1.22+9.8%

1.11-16.3%

1.33

49.14-24.9%

65.43-9%

71.88-39%

117.78

Liquidity

€4,591,821-20.8%

€5,797,695+33.1%

€4,355,909-6.4%

€4,654,847

€28,548,483+7.8%

€26,477,796+19.3%

€22,199,948-10.1%

€24,702,125

€15,941,226+19.5%

€13,338,545+11.5%

€11,968,712+25.3%

€9,548,758

€47,211,169+3.2%

€45,756,302+27.8%

€35,813,483-8.3%

€39,061,645

€50,500,183+4.9%

€48,139,351+26.7%

€38,000,708-7.9%

€41,279,137

0.81+1.5%

0.80-4.9%

0.84+7.3%

0.79

-€6,135,870-28.8%

-€4,765,136-98.4%

-€2,402,144+53.7%

-€5,188,911

Efficiency

46 days+8.2%

42 days-2.8%

44 days+25.9%

35 days

128 days-7.5%

138 days+9.3%

126 days-9%

139 days

103 days-3%

107 days+1.1%

105 days-7.9%

114 days

3.66-1.9%

3.73+13.7%

3.28+0.3%

3.27

Profit appropriation

€13,853,899+7.7%

€12,864,549+8.3%

€11,875,199+9.1%

€10,885,849

€31,423,458+18.5%

€26,522,555+16.7%

€22,734,567+17%

€19,435,125

HuVePharma

Activities

Financials

Frequently asked questions

All locations

All locations